WO2008034928A1 - Gel de séparation de protéines - Google Patents
Gel de séparation de protéines Download PDFInfo
- Publication number
- WO2008034928A1 WO2008034928A1 PCT/ES2007/000535 ES2007000535W WO2008034928A1 WO 2008034928 A1 WO2008034928 A1 WO 2008034928A1 ES 2007000535 W ES2007000535 W ES 2007000535W WO 2008034928 A1 WO2008034928 A1 WO 2008034928A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- acrylamide
- range
- gel
- crosslinker
- polyacrylamide
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 49
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 49
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims abstract description 43
- 229920002401 polyacrylamide Polymers 0.000 claims abstract description 38
- 239000004971 Cross linker Substances 0.000 claims abstract description 37
- 238000000034 method Methods 0.000 claims abstract description 19
- 238000000926 separation method Methods 0.000 claims abstract description 9
- 230000008569 process Effects 0.000 claims abstract description 6
- 239000002356 single layer Substances 0.000 claims abstract description 6
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical group C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 claims description 11
- 238000001962 electrophoresis Methods 0.000 claims description 8
- 239000000872 buffer Substances 0.000 claims description 6
- 239000000499 gel Substances 0.000 description 59
- 239000000243 solution Substances 0.000 description 15
- 108020001507 fusion proteins Proteins 0.000 description 9
- 102000037865 fusion proteins Human genes 0.000 description 9
- 239000012528 membrane Substances 0.000 description 8
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 8
- 101000872514 Homo sapiens Probable E3 ubiquitin-protein ligase HERC1 Proteins 0.000 description 7
- 102100034747 Probable E3 ubiquitin-protein ligase HERC1 Human genes 0.000 description 7
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 7
- 210000002806 clathrin-coated vesicle Anatomy 0.000 description 6
- 238000003119 immunoblot Methods 0.000 description 6
- 238000001262 western blot Methods 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 5
- 102000036801 ADP-Ribosylation Factor 1 Human genes 0.000 description 4
- 108010016281 ADP-Ribosylation Factor 1 Proteins 0.000 description 4
- 238000001502 gel electrophoresis Methods 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- 239000003638 chemical reducing agent Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 229920006037 cross link polymer Polymers 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000001114 immunoprecipitation Methods 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical group OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- 208000019698 Cutaneous collagenous vasculopathy Diseases 0.000 description 2
- 102100031635 Cytoplasmic dynein 1 heavy chain 1 Human genes 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 101710165788 Dynein heavy chain, cytoplasmic Proteins 0.000 description 2
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 2
- 239000012935 ammoniumperoxodisulfate Substances 0.000 description 2
- 201000009911 cataract 8 multiple types Diseases 0.000 description 2
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 2
- 102000013035 dynein heavy chain Human genes 0.000 description 2
- 108060002430 dynein heavy chain Proteins 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- VADKRMSMGWJZCF-UHFFFAOYSA-N 2-bromophenol Chemical compound OC1=CC=CC=C1Br VADKRMSMGWJZCF-UHFFFAOYSA-N 0.000 description 1
- MTPJEFOSTIKRSS-UHFFFAOYSA-N 3-(dimethylamino)propanenitrile Chemical compound CN(C)CCC#N MTPJEFOSTIKRSS-UHFFFAOYSA-N 0.000 description 1
- 108010039627 Aprotinin Proteins 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 102000003846 Carbonic anhydrases Human genes 0.000 description 1
- 108090000209 Carbonic anhydrases Proteins 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 108010036652 HSC70 Heat-Shock Proteins Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000003505 Myosin Human genes 0.000 description 1
- 108060008487 Myosin Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- 101710162629 Trypsin inhibitor Proteins 0.000 description 1
- 229940122618 Trypsin inhibitor Drugs 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- -1 amine compounds Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960004405 aprotinin Drugs 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- IUNMPGNGSSIWFP-UHFFFAOYSA-N dimethylaminopropylamine Chemical compound CN(C)CCCN IUNMPGNGSSIWFP-UHFFFAOYSA-N 0.000 description 1
- 239000012971 dimethylpiperazine Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- CHDKQNHKDMEASZ-UHFFFAOYSA-N n-prop-2-enoylprop-2-enamide Chemical compound C=CC(=O)NC(=O)C=C CHDKQNHKDMEASZ-UHFFFAOYSA-N 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 229940092253 ovalbumin Drugs 0.000 description 1
- NXGWSWBWEQYMND-UHFFFAOYSA-N piperazine;prop-2-enamide Chemical compound NC(=O)C=C.NC(=O)C=C.C1CNCCN1 NXGWSWBWEQYMND-UHFFFAOYSA-N 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002753 trypsin inhibitor Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F2/00—Processes of polymerisation
- C08F2/04—Polymerisation in solution
- C08F2/10—Aqueous solvent
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F120/00—Homopolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
- C08F120/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F120/52—Amides or imides
- C08F120/54—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
- C08F120/56—Acrylamide; Methacrylamide
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F265/00—Macromolecular compounds obtained by polymerising monomers on to polymers of unsaturated monocarboxylic acids or derivatives thereof as defined in group C08F20/00
- C08F265/10—Macromolecular compounds obtained by polymerising monomers on to polymers of unsaturated monocarboxylic acids or derivatives thereof as defined in group C08F20/00 on to polymers of amides or imides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
- G01N27/44704—Details; Accessories
- G01N27/44747—Composition of gel or of carrier mixture
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
- G01N27/44756—Apparatus specially adapted therefor
- G01N27/44782—Apparatus specially adapted therefor of a plurality of samples
Definitions
- the invention relates to gel electrophoresis and particularly with a polyacrylamide gel for protein separation as well as with a method for obtaining the gel.
- Gel electrophoresis configures a group of techniques used by scientists to separate molecules based on their physical characteristics such as their size, shape or isoelectric point. Gel electrophoresis is normally used for analytical purposes although it can also be used as a preparatory technique for the partial purification of molecules prior to its use in other methods for its characterization, such as mass spectrometry, PCR (in English, “Polymerase Chain Reaction "), cloning, DNA sequencing or immunoblotting.
- PAGE polyacrylamide gel electrophoresis
- This anionic detergent binds along the entire surface of heat-denatured proteins, thereby conferring them a total charge that is proportional to their size (ie, a mass ratio: uniform charge).
- SDS anionic detergent
- the migration distance of a protein when an electric current is applied to an SDS-PAGE gel depends solely on the mass of the protein.
- This fact together with some other refinements such as the use of reducing agents and the use of a concentrating gel has made it possible to separate proteins according to their molecular weight with considerable resolution. To obtain an optimal protein resolution by SDS-PAGE, it is necessary to pour a concentrating gel on the separating gel.
- the concentrating gel has a lower concentration of acrylamide (larger pore size), a lower pH and a different ionic content. This allows the proteins of each lane to concentrate in a narrow band, before entering the separator gel, producing a gel with narrower and better separated protein bands.
- SDS-PAGE is a known technique for the separation of small proteins.
- a gel with a polyacrylamide concentration between 5 and 20% and an acrylamide: bisacrylamide ratio of around 40: 1 is normally used for the analysis of proteins from 5 to 200 kDa (cf. AV Ershov et al., 1996, The Journal of Bioloqical Chemistrv. Vol. 271, pp. 28458-28462).
- a compound gel with a higher porosity is used. This gel is achieved by increasing the acrylamide: bisacrylamide ratio to 80: 1 for example. A low acrylamide percentage of about 4-5% is also necessary (cf. J. L. Rosa et al., 1996, EMBQ J .. vol. 15, pp. 4262-73).
- these types of gels are too soft and sticky, which makes them difficult to manipulate in stains or to transfer them into membranes.
- the present invention relates to a new polyacrylamide gel capable of simultaneously separating high and low molecular weight proteins (i.e., proteins with a molecular weight in the range of 5 kDa to greater than 200 kDa), where this gel comprises a uniform layer formed by different solutions, all polymerized at the same time.
- high and low molecular weight proteins i.e., proteins with a molecular weight in the range of 5 kDa to greater than 200 kDa
- the polyacrylamide gel of the invention it is possible to simultaneously analyze giant proteins such as HERC1 (532 kDa) and the heavy chain of the dynein (DYHC, 527 kDa), large proteins such as the heavy chain of the clatrine (CHC, 192 kDa) and small proteins such as ADP ribosylation factor 1 (ARF1, 20 kDa).
- the polyacrylamide gel of the invention has a good resolution, low manufacturing cost, high reproducibility and saves time compared to the gel systems used in the technique. All these characteristics, together with the fact that a standard apparatus available in any biochemistry laboratory can be used to make the gel of the present invention, makes it an easy and reliable tool.
- a first aspect of the present invention refers to a polyacrylamide gel comprising: (i) a lower part having a gradient of polyacrylamide concentration within the range of 3% to 20% and an acrylamide: crosslinker ratio selected within from the range of 60: 1 to 20: 1; and (i) a top portion having a polyacrylamide concentration (fixed or gradient) in the range of 3% to 10% and an acrylamide: crosslinker ratio selected within the range of 100: 1 to 70: 1; where both parts form a single layer.
- single layer refers to a uniform gel with no separation or deformation between the two parts.
- both parts must be polymerized at the same time.
- the final gel is a more consistent unit and can be manipulated by taking it through its denser lower region. This is especially important when the gel has to be dyed or transferred to a membrane to perform eg a western blot.
- a person skilled in the art will easily understand the meaning of the terms “upper part” and "lower part” of a gel.
- the lower part has a concentration gradient of polyacrylamide within the range of 4% at 18% and an acrylamide: crosslinker ratio selected within the range of 50: 1 to 30: 1.
- the upper part has a polyacrylamide concentration in the range of 4% to 8% and an acrylamide: crosslinker ratio selected within the range of 90: 1 to 80: 1.
- the lower part has a gradient of polyacrylamide concentration from 6% to 15% and an acrylamide: crosslinker ratio of 40: 1.
- the upper part has a polyacrylamide concentration of 4% and an acrylamide: crosslinker ratio of 80: 1.
- a second aspect of the present invention relates to a process for obtaining the gel of the invention, which comprises the following steps: (a) pouring into a gradient generator solutions comprising acrylamide and crosslinker, suitable for obtaining a concentration gradient of polyacrylamide within the range of 3% to 20% and an acrylamide: crosslinker ratio selected within the range of 60: 1 to 20: 1; (b) adding a second solution comprising acrylamide and crosslinker, suitable for obtaining a polyacrylamide concentration in the range of 3% to 10% and an acrylamide: crosslinker ratio selected within the range of 100: 1 to 70: 1; and (c) allow the solutions of steps (a) and (b) to be polymerized at the same time to form a single layer.
- the acrylamide that is used to make the solutions of steps (a) and (b) of the process of the invention has to be mixed with a crosslinker in order to form the crosslinked polymer.
- this polymerization must be done in the presence of a peroxide solution and a reducing agent.
- the peroxide solution, which is used to form the crosslinked polymer can be, but is not limited to, ammonium peroxodisulfate, and an alkali metal peroxodisulfate.
- the reducing agents that are used to form the crosslinked polymer may be, but are not limited to, amine compounds, eg N, N, N ', N'-tetramethylethenediamine (TEMED) , N 1 N, - dimethylethylenediamine, 3-dimethylamino-n-propylamine, 3- dimethylaminopropionitrile, Nn-butyldimethylamine and N. N'-dimethylpiperazine.
- the gradient in step (a) has a polyacrylamide concentration within the range of 4% to 18%, and an acrylamide: crosslinker ratio selected within the range of 50: 1 to 30: 1; and in step (b) the polyacrylamide concentration is in the range of 4% to 8%, and has an acrylamide: crosslinker ratio selected within the range of 90: 1 to 80: 1.
- step (a) the gradient has a polyacrylamide concentration from 6% to 15%, and an acrylamide: crosslinker ratio of 40: 1; and in step (b) the concentration of polacrylamide is 4% and the acrylamide: crosslinker ratio of 80: 1.
- crosslinker refers to any compound that has cross-linking functions. Specific examples of compounds may be, but are not limited to, N 1 N'-methylenebisacrylamide (BIS or bisacrylamide), N. N'-propylenenebisacrylamide, diacrylamide dimethyl ether and piperazine diacrylamide. In still a more preferred embodiment of the present invention, the crosslinker is bisacrylamide.
- a third aspect of the present invention refers to the use of the gel of the invention for the separation of proteins by electrophoresis.
- the gel of the invention is used to simultaneously separate proteins of very different sizes.
- the lower part of the gel of the invention is capable of separating proteins whose molecular weights are in the range of 5 kDa to 200 kDa and the upper part of the gel is capable of separating proteins whose molecular weights are greater than 200 kDa, with good resolution.
- kits for carrying out the process defined above which comprises appropriate amounts of acrylamide, crosslinker and a suitable buffer.
- a suitable buffer can be Tris / HCI (pH 8.8) + SDS.
- FIG. 1 A is a schematic representation showing how the gel of the invention is prepared, between two crystals of an apparatus for Western blot ("slab").
- FIG. 2 shows some applications of the gel.
- FIG. 2A is a schematic representation of different fusion proteins with GFP, of the giant HERC1 protein and its domains.
- FIG. 2B and FIG. 2C show plasmids expressing GFP fusion proteins, transfected into HEK-293 cells and analyzed by "immunoblot" with anti-GFP (FIG. 2B) or anti-HERC1 (FIG. 2C) antibodies.
- FIG. Used 2D sample of HEK-293 cells immunoprecipitated with antibodies against HERC1, preimmune (P) or immune (I).
- FIG. 1 An example of the gel of the invention is shown in FIG 1.
- the gel was prepared between two crystals (16 cm x 18 cm) of a standard Western blot apparatus (cf. FWStudier, 2000 TIBS. Vol. 35, pp. 588-590),
- a standard Western blot apparatus cf. FWStudier, 2000 TIBS. Vol. 35, pp. 588-590
- three solutions of acrylamide with bisacrylamide were prepared. These solutions had the following characteristics:
- CMV clathrin-coated vesicles
- the molecular weight markers are shown in the figures (Myosin: 195 kDa; ⁇ -galactosidase: 116 kDa; Bovine serum albumin: 95 kDa;
- Ovalbumin 51 kDa; Carbonic anhydrase: 37 kDa; Trypsin inhibitor of soybean seed: 29 kDa; Lysozyme: 20 kDa; Aprotinin: 7 kDa) (BioRad laboratories, Hercules, CA, USA).
- Example 1 were visualized by staining with Coomassie Brilliant Blue and then were identified by mass spectrometry (MS) and mmunoblot with specific antibodies.
- MS mass spectrometry
- the gel was stained with Coomassie Brilliant Blue, whereby the molecular weight markers showed the good resolution of this system (FIG. 1 B).
- the staining shows a wide range of proteins with very different molecular weights.
- the subsequent identification by proteomics confirmed the separation in the same gel of giant proteins, such as the heavy chain of the dynein (DYHC, 527 kDa), large proteins such as the heavy chain of the clatrine (CHC, 192 kDa), medium proteins such as Ia chaperone Hsc70 (72 kDa) or synaptotagmine I (Syt I, 65 kDa), and small proteins such as ADP ribosylation factor 1 (ARF1, 20 kDa).
- giant proteins such as the heavy chain of the dynein (DYHC, 527 kDa), large proteins such as the heavy chain of the clatrine (CHC, 192 kDa), medium proteins such as Ia chaperone Hsc70 (72 k
- PVDF Polyvinylidene difluoride
- Plasmids expressing the indicated fusion proteins were transfected into HEK-293 cells (FIG. 2B, 2C). 48 hours later, used of these cells were analyzed with the gel and transferred to a PVDF membrane as previously indicated. GFP fusion proteins were identified by incubation with anti-GFP monoclonal antibodies. (Roche). As shown in FIG. 2B, all GFP fusion proteins were detected in the same membrane, observing as expected a decrease in the degree of expression of fusion proteins directly proportional to their sizes. In this way, smaller fusion proteins such as PFG40 were detected more quickly than larger proteins such as giant protein pFG43, which could be clearly detected with anti HERCI antibodies (FIG. 2C).
- HERC1 By way of another application of electrophoresis of SDS-PAGE proteins, immunoprecipitation of HERC1 was performed with specific anti-HERC1 antibodies in used HEK-293 cells.
- HERC1 and its associated proteins CHC: clatrine heavy chain; Hsp 70; CLC: Clatrine light chain
- CHC clatrine heavy chain
- Hsp 70 Hsp 70
- CLC Clatrine light chain
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Electrochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Peptides Or Proteins (AREA)
Abstract
L'invention se rapporte à un gel de polyacrylamide qui comprend : (i) une partie inférieure présentant un gradient de concentration de polyacrylamide compris entre 3 et 20 % et un rapport acrylamide:entrecroiseur sélectionné dans l'intervalle compris entre 60:1 et 20:1; et (ii) une partie supérieure présentant une concentration de polyacrylamide compris entre 3 et 10 % et un rapport acrylamide:entrecroiseur sélectionné dans l'intervalle de 100:1 à 70:1, où les deux parties forment une couche unique. L'invention se rapporte également au procédé et au kit d'obtention de ce gel de polyacrylamide utilisé pour séparer simultanément par électrophorèse des protéines à poids moléculaire élevé et faible.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ESP200602462 | 2006-09-22 | ||
ES200602462A ES2294949B1 (es) | 2006-09-22 | 2006-09-22 | Gel para la separacion de proteinas. |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008034928A1 true WO2008034928A1 (fr) | 2008-03-27 |
Family
ID=39167914
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/ES2007/000535 WO2008034928A1 (fr) | 2006-09-22 | 2007-09-20 | Gel de séparation de protéines |
Country Status (2)
Country | Link |
---|---|
ES (1) | ES2294949B1 (fr) |
WO (1) | WO2008034928A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103013982A (zh) * | 2012-12-28 | 2013-04-03 | 上海启动元生物科技有限公司 | 一种快速灌制聚丙烯酰胺凝胶的试剂盒及其应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996032628A2 (fr) * | 1995-04-04 | 1996-10-17 | Amresco, Inc. | Gels polyacrylamide reticules presentant des rapports monomere/agent de reticulation eleves |
US5925229A (en) * | 1996-05-03 | 1999-07-20 | The Regents Of The University Of California | Low density lipoprotein fraction assay for cardiac disease risk |
US20050059761A1 (en) * | 2002-02-27 | 2005-03-17 | Bio-Rad Laboratories, Inc., A Corporation Of The State Of Delaware | Preparation of defect-free polyacrylamide electrophoresis gels in plastic cassettes |
-
2006
- 2006-09-22 ES ES200602462A patent/ES2294949B1/es active Active
-
2007
- 2007-09-20 WO PCT/ES2007/000535 patent/WO2008034928A1/fr active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996032628A2 (fr) * | 1995-04-04 | 1996-10-17 | Amresco, Inc. | Gels polyacrylamide reticules presentant des rapports monomere/agent de reticulation eleves |
US5925229A (en) * | 1996-05-03 | 1999-07-20 | The Regents Of The University Of California | Low density lipoprotein fraction assay for cardiac disease risk |
US20050059761A1 (en) * | 2002-02-27 | 2005-03-17 | Bio-Rad Laboratories, Inc., A Corporation Of The State Of Delaware | Preparation of defect-free polyacrylamide electrophoresis gels in plastic cassettes |
Non-Patent Citations (4)
Title |
---|
CAMPBELL W.P. ET AL.: "Electrophoresis of small proteins in highly concentrated and crosslinked polyacrylamide gradient gels", ANAL. BIOCHEM., vol. 129, 1983, pages 31 - 36, XP024825322, DOI: doi:10.1016/0003-2697(83)90047-7 * |
CASAS-TERRADELLAS E. ET AL.: "Simultaneous electrophoretic analysis of proteins of very high and low molecular weights using low-percentage acrylamide gel and a gradient SDS-PAGE gel", ELECTROPHORESIS, vol. 27, no. 20, 20 October 2006 (2006-10-20), pages 3935 - 3938 * |
KHALKHALI-ELLIS Z.: "An improved SDS-polyacrylamide gel electrophoresis for resolution of peptides in the range of 3.5-200 KDa", PREP. BIOCHEM., vol. 25, no. 1&2, 1995, pages 1 - 9 * |
MARGOLIS J. ET AL.: "Improvement of pore gradient electrophoresis by increasing the degree of cross-linking at high acrylamide concentrations", J. CHROMATOGR., vol. 106, 1975, pages 204 - 209, XP026475087, DOI: doi:10.1016/S0021-9673(01)81066-9 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103013982A (zh) * | 2012-12-28 | 2013-04-03 | 上海启动元生物科技有限公司 | 一种快速灌制聚丙烯酰胺凝胶的试剂盒及其应用 |
Also Published As
Publication number | Publication date |
---|---|
ES2294949B1 (es) | 2009-04-01 |
ES2294949A1 (es) | 2008-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8945361B2 (en) | Electrophoresis standards, methods and kits | |
Manz et al. | Bioanalytical chemistry | |
JP4434955B2 (ja) | 蛋白質結合膜上での蛋白質の電気泳動分離用システム及び方法 | |
EP0753142B1 (fr) | Système d'électrophorèse de gel | |
US6638408B1 (en) | Method and device for separation of charged molecules by solution isoelectric focusing | |
US20090314638A1 (en) | Methods and Compositions for Capillary Electrophoresis | |
Willard et al. | Analytical techniques for cell fractions: XXVI. A two-dimensional electrophoretic analysis of basic proteins using phosphatidyl choline/urea solubilization | |
JPH06506779A (ja) | 動的架橋組成物を含む毛管カラムおよびその使用方法 | |
CN102138073B (zh) | 抗水解的聚丙烯酰胺凝胶 | |
JPH08220069A (ja) | 低導電率緩衝液中での電気泳動方法 | |
US20130008795A1 (en) | Electrophoresis apparatus | |
Busnel et al. | Evaluation of capillary isoelectric focusing in glycerol‐water media with a view to hydrophobic protein applications | |
Gallagher | One‐dimensional SDS gel electrophoresis of proteins | |
US9150611B2 (en) | Aqueous transfer buffer | |
US20140114053A1 (en) | Electrophoresis Separation Methods | |
ES2294949B1 (es) | Gel para la separacion de proteinas. | |
US20110308951A1 (en) | Long-lasting precast electrophoresis gel | |
Görg et al. | 2-D electrophoresis with immobilized pH gradients using IPGphor isoelectric focusing system | |
JP2005084047A (ja) | たんぱく質分離用高速二次元電気泳動システム | |
Kavoosi et al. | Gel electrophoresis of protein–from basic science to practical approach | |
Usui et al. | A self‐contained polymeric 2‐DE chip system for rapid and easy analysis | |
Changa et al. | Advanced capillary and microchip electrophoretic techniques for proteomics | |
Perrett | 200 years of Electrophoresis | |
US20040108209A1 (en) | Electrophoresis separation methods | |
Kim et al. | Development of a novel ampholyte buffer for isoelectric focusing: electric charge-separation of protein samples for X-ray crystallography using free-flow isoelectric focusing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07822942 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07822942 Country of ref document: EP Kind code of ref document: A1 |